Research Reports

Topic: 会员增长对运营能力的影响
Key points:
- 管理层聚焦会员终身价值（LTV）和净现值（NPV），增长是LTV策略的结果。
- 过去两年削减福利并退出低利润市场，2025年计划通过稳定计划利润（而非依赖低利润计划）驱动增长。
- 未分享运营可承受的具体增长数字，正在动态平衡新会员增长与运营容量。
Mgmt stance: 中性偏谨慎——强调长期价值而非短期增长，但未提供量化目标。

Topic: 会员组合多元化策略进展
Key points:
- 目标：去集中化H5216合同（目前占会员比例43%–45%），将其降至更均衡的合同组合以降低单一合同风险。
- 2025年AEP已向4–4.5星合同转移会员，取得“实质性进展”，但AEP仅过两周，无法提供具体数字。
- 完全完成去集中化预计需2–3个产品周期。
Mgmt stance: 中性偏乐观——方向明确且已迈出第一步，但未量化进展。

Topic: 会员增长预期与完全风险协议占比
Key points:
- 会员增长：不提供具体数字，因需考虑成员组合、产品组合及渠道组合，运营能力正在根据AEP动态调整。
- 完全风险协议：已采取行动（如收回Part D风险、削减福利以重置产品），同时实施Stars缓解计划以帮助价值导向合作伙伴应对IRA影响。
- 未提供2025/2026年完全风险成员占比数字。
Mgmt stance: 中性偏乐观——通过风险管理措施（如Part D风险收回）加强合作，但未量化进展。

Topic: 2026年新会员利润率假设
Key points:
- 2026年指引过于早期，无法提供（目前处于AEP期间）。
- 新会员利润率取决于所在合同星级（4–4.5星合同利润率更高），但整体预期：2026年个人MA利润率（排除Stars影响）将在2025年基础上翻倍。
- 管理层对进入AEP前的产品设计和渠道组合感到满意，预期新会员利润率与整体利润率保持一致。
Mgmt stance: 中性偏乐观——确认利润率趋势符合投资者日指引，但强调受合同组合影响。

Topic: Membership quality drivers and margin differentials
Key points:
- Management declined to give explicit margin information by channel.
- Better attrition/retention rates, different cost of acquisition, and different engagement rates (Stars, accurate diagnosis, medical management) vary by channel.
- Reduced plan-to-plan sales is correlated with better retention, but actual retention data is not yet available.
Mgmt stance: Neutral — they acknowledge data limitations and refuse to quantify margin differentials, but highlight qualitative factors supporting membership quality.

Topic: Strategic shift to LTV/NPV focus and impact on margins
Key points:
- The LTV/NPV focus is described as an "evolution," not a shift; it has always been part of the company’s thinking.
- LTV requires both margin and retention; the goal is to avoid low-margin, high-growth products that require margin recovery in later years.
- Integrated health (CenterWell) is a key differentiator, and enterprise-wide customer lifetime value is now used to evaluate all activities.
Mgmt stance: Bullish — they emphasize a multiyear view for better stability and long-term value, while balancing short-term delivery (per Celeste Mellet).

Topic: MA market growth, plan exits, and mitigation levers
Key points:
- Management expects mid-single-digit MA market growth, similar to last year; they note CMS forecasts are historically inaccurate.
- They do not see a material difference in market dynamics versus last year.
- Mitigation levers include decommissioned plans (already done), owning a large part of their own distribution, and using internal marketing to match volume with operational capacity.
Mgmt stance: Neutral — they acknowledge uncertainty (forecasts are never right) but express confidence in their ability to manage growth through owned distribution and other levers.

Topic: 2025 MA membership decline and impact on 2026 margin doubling
Key points:
- Better-than-expected membership decline in 2025 was driven by better retention and marginally better sales, especially later in the year.
- There is no impact to prior MLR expectations from the pickup in membership.
- No direct comment on how retention contributes to the 2026 margin doubling target.
Mgmt stance: Neutral — they confirm no change to 2025 MLR expectations but do not elaborate on 2026 margin implications.

Topic: AEP sales mix (PPO/HMO/D-SNP) and LIS PDP growth sources
Key points:
- It is too early to project detailed product mix; growth is healthy across all segments and geographies, with no disproportionate concentration.
- PDP growth is expected to come from basic and value plans; the company is below the benchmark in about twice the number of states as in 2025, leading to significant auto-enrollee pickup (including competitor reassignments).
- LIS PDP business is considered "good business."
Mgmt stance: Bullish — they view the PDP benchmark positioning and auto-enrollee pickup as a very positive development.